83 results on '"Slomovich S"'
Search Results
2. Molecular Microscope Findings in Low-Grade Histological Rejection: A Less Benign Reality Than Assumed
3. Clinical Utility of Molecular Microscope Diagnostic System (MMDx) in Heart Transplant Recipients: Moving Towards a New Paradigm
4. Impact of MTOR Inhibitors on Heart Allograft Rejection Using Tissue-Based Gene-Expression Profiling. Molecular Microscope (MMDx) Results
5. Impact of Race Mismatch in Allograft Rejection After Heart Transplantation. Molecular Microscope (MMDx) Results
6. LVAD Bridge to Transplant and Rejection Assessed by Molecular Microscope
7. Correlation Between Peripheral Gene-Expression Profiling (GEP-Allomap) and Tissue Gene-Expression in T-Cell Mediated Rejection Detection
8. Clinical Implications of Borderline Rejection Assessed by Molecular Microscope
9. Correlation Between Donor-Derived Cell-Free DNA (dd-cfDNA) and Molecular Microscope (MMDx) in Heart Transplant Recipients
10. Impact of Cytomegalovirus (CMV) Mismatch on Rejection Assessed by Molecular Microscope (MMDx)
11. (230) The Effect of Preservation Modality on Myocardial Injury - A Single Blinded Study
12. (1029) Donor-Derived Cell-Free DNA in Heart Transplant Recipients with a History of Congenital Heart Disease
13. (494) The Utility and Characteristics of Cardiovascular Magnetic Resonance Imaging in Suspected Chronic Allograft Rejection
14. Fractional flow reserve versus angiography guided revascularization for patients with multivessel coronary artery disease: a systematic review and meta-analysis of randomized controlled trials
15. (458) - History of Malignancy and Rejection Outcomes Assessed by Molecular Microscope (MMDx)
16. (418) - Clinical Utility of Molecular Microscope Diagnostic System (MMDx) in Heart Transplant Recipients: Moving Towards a New Paradigm
17. (417) - Clinical Implications of Borderline Rejection Assessed by Molecular Microscope
18. (419) - Impact of MTOR Inhibitors on Heart Allograft Rejection Using Tissue-Based Gene-Expression Profiling. Molecular Microscope (MMDx) Results
19. (416) - Impact of Race Mismatch in Allograft Rejection After Heart Transplantation. Molecular Microscope (MMDx) Results
20. (1085) - LVAD Bridge to Transplant and Rejection Assessed by Molecular Microscope
21. (780) - Impact of Cytomegalovirus (CMV) Mismatch on Rejection Assessed by Molecular Microscope (MMDx)
22. (779) - Correlation Between Peripheral Gene-Expression Profiling (GEP-Allomap) and Tissue Gene-Expression in T-Cell Mediated Rejection Detection
23. (762) - Molecular Microscope Findings in Low-Grade Histological Rejection: A Less Benign Reality Than Assumed
24. (348) - Correlation Between Donor-Derived Cell-Free DNA (dd-cfDNA) and Molecular Microscope (MMDx) in Heart Transplant Recipients
25. Clinical Characteristics and Outcomes of Cancer Survivors Undergoing Heart Transplantation
26. The Utility of Televisits in Patients with a Left Ventricular Assist Device
27. The Utility of Televisits in Heart Transplant Recipients
28. Remote Monitoring of Heart Transplant Recipients during the COVID-19 Pandemic
29. The Safety of a Non-Invasive Monitoring Protocol in Heart Transplant Recipients
30. The Utility of Televisits in Patients with Cardiac Amyloidosis during the COVID-19 Pandemic
31. (276) Donor-Derived Cell-Free Dna in Heart Transplant Recipients with Microvascular Cardiac Allograft Vasculopathy
32. (1060) The Hemodynamic Effects of Pump Speed Adjustments in Patients with Heartmate 3 Left Ventricular Assist Device
33. (758) Evaluation of Donor Derived Cell-Free DNA in ABO Mismatched Heart Transplant Patients
34. (565) Donor-Derived Cell-Free DNA in Cancer Survivors Following Heart Transplantation
35. (564) The Effect of Persistently Elevated Dd-Cfdna with De-Novo Donor Specific Antibody on Heart Transplant Recipients Outcomes
36. (563) Persistently Elevated Donor-Derived Cell-Free DNA in Heart Transplant Recipients
37. (562) Donor-Derived Cell-Free DNA in Heart Transplant Recipients Bridged with Left Ventricular Assist Device
38. (514) Clinical Utility of Donor Derived Cell-Free DNA in the Multiorgan Transplantation
39. (451) Donor-Derived Cell-Free DNA in Heart Transplant Recipients with Coronary Allograft Vasculopathy
40. Donor-Derived Cell-Free DNA in Cancer Survivors Following Heart Transplantation.
41. (458) - History of Malignancy and Rejection Outcomes Assessed by Molecular Microscope (MMDx).
42. (419) - Impact of MTOR Inhibitors on Heart Allograft Rejection Using Tissue-Based Gene-Expression Profiling. Molecular Microscope (MMDx) Results.
43. (417) - Clinical Implications of Borderline Rejection Assessed by Molecular Microscope.
44. (418) - Clinical Utility of Molecular Microscope Diagnostic System (MMDx) in Heart Transplant Recipients: Moving Towards a New Paradigm.
45. (416) - Impact of Race Mismatch in Allograft Rejection After Heart Transplantation. Molecular Microscope (MMDx) Results.
46. (1085) - LVAD Bridge to Transplant and Rejection Assessed by Molecular Microscope.
47. (780) - Impact of Cytomegalovirus (CMV) Mismatch on Rejection Assessed by Molecular Microscope (MMDx).
48. (779) - Correlation Between Peripheral Gene-Expression Profiling (GEP-Allomap) and Tissue Gene-Expression in T-Cell Mediated Rejection Detection.
49. (762) - Molecular Microscope Findings in Low-Grade Histological Rejection: A Less Benign Reality Than Assumed.
50. (348) - Correlation Between Donor-Derived Cell-Free DNA (dd-cfDNA) and Molecular Microscope (MMDx) in Heart Transplant Recipients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.